Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07401797 · ClinicalTrials.gov registry record
Specimens for Lung Cancer Panel Design
A clinical trial of Lung Nodules, sponsored by Maverix Medical.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT07401797 is a study of Lung Nodules that is actively recruiting participants, run by Maverix Medical. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07401797, a study of Lung Nodules, is actively recruiting participants, sponsored by Maverix Medical.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Conditions Studied
Study Locations (1)
Arizona
- Maverix Medical - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07401797
The ClinicalTrials.gov registry entry for NCT07401797 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maverix Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Nodules appearing as the primary indexed condition, and to 0 interventions.
NCT07401797 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT07401797 about?
NCT07401797 is a clinical study titled "Specimens for Lung Cancer Panel Design". This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
What is the current status of trial NCT07401797?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-08-07. Estimated completion is 2029-12-31.
What conditions does trial NCT07401797 study?
This clinical trial studies the following conditions: Lung Nodules.
Who is sponsoring clinical trial NCT07401797?
This trial is sponsored by Maverix Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07401797 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.